The measurement of indirect costs in the health economics evaluation literature - A review

被引:55
作者
Jacobs, P [1 ]
Fassbender, K [1 ]
机构
[1] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB T6G 2G3, Canada
关键词
cost; cost analysis; indirect costs; economic evaluation;
D O I
10.1017/S0266462300012095
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In this gaper we develop a framework to categorize the concepts used to estimate indirect costs in economic evaluation, We apply this framework in a literature review of economic evaluation studies. We searched all English language literature from 1994-96. Following the application of a search algorithm, which yielded 25 articles, we abstracted information from these articles to determine the methods used to identify the relative contribution of indirect costs to the cost-effectiveness ratio, the rime horizon selected by the authors, the identification of those activities that were foregone, the time given up by these activities, and the valuation placed on this time. These methods were then assessed. Indirect costs, as they have been measured, significantly influence efficiency ratios. A wide variation exists among studies in how they incorporate each of the components of indirect costs. All of the four components that were identified will affect the measurement of indirect cost. Future guidelines in this area should address the entire measurement process.
引用
收藏
页码:799 / 808
页数:10
相关论文
共 46 条
[1]   AN ECONOMIC-ANALYSIS OF STRATEGIES FOR THE USE OF CONTRAST-MEDIA FOR DIAGNOSTIC CARDIAC-CATHETERIZATION [J].
BARRETT, BJ ;
PARFREY, PS ;
FOLEY, RN ;
DETSKY, AS .
MEDICAL DECISION MAKING, 1994, 14 (04) :325-335
[2]   A cost-minimization analysis of laparoscopic cholecystectomy versus open cholecystectomy [J].
Berggren, U ;
Zethraeus, N ;
Arvidsson, D ;
Haglund, U ;
Jonsson, B .
AMERICAN JOURNAL OF SURGERY, 1996, 172 (04) :305-310
[3]  
BERMAN S, 1994, PEDIATRICS, V93, P353
[4]  
Bostman OM, 1996, CLIN ORTHOP RELAT R, P233
[5]  
Brouwer WBF, 1997, HEALTH ECON, V6, P511, DOI 10.1002/(SICI)1099-1050(199709)6:5<511::AID-HEC297>3.0.CO
[6]  
2-K
[7]  
*CAN COORD OFF HLT, 1996, GUID DOC CAST PROC V
[8]  
Canadian Co-ordinating Office for Health Technology Assessment , 1997, GUID EC EV PHARM CAN
[9]  
*COMM DEP HUM SERV, 1995, AUSTR GUID
[10]   A COST-UTILITY ANALYSIS OF TREATMENT OPTIONS FOR GALLSTONE DISEASE - METHODOLOGICAL ISSUES AND RESULTS [J].
COOK, J ;
RICHARDSON, J ;
STREET, A .
HEALTH ECONOMICS, 1994, 3 (03) :157-168